Skip to main content
  • Letter to the Editor
  • Open access
  • Published:

Infodemic and the fear of monkeypox: call for action

This article has been updated

Abstract

Monkeypox (MPX) was declared a public health emergency of international concern by the World Health Organization (WHO), as of July 23rd, 2022. Fake news spread on social media has already surfaced and contributed to worsening of this concerning situation, making it difficult for the health care experts’ voices to be heard. Therefore, we recommend some solutions to overcome this situation, including raising public awareness and preventing stigma through sharing engagement with civil society organizations, and better cooperation between policymakers, the medical community, and social media platforms regarding providing accurate official news about MPX. WHO-one health approach should be established and prioritized.

Monkeypox (MPX) has infected more than 40,932 cases across 90 countries as of August 22nd, 2022 [1]. MPX was declared a public health emergency of international concern by the World Health Organization (WHO), as of July 23rd, 2022. Although MPX is transmitted through close contact with infected lesions, respiratory droplets, bodily fluids, and contaminated objects (i.e., fomites), it has mainly spread among males who have sex with males [2]. There has been extensive coverage of the outbreak from mainstream news agencies and social media sites.

Fake news is defined as the dissemination of incorrect information using digital or traditional media. Users' newsfeeds on social media sites (i.e., Facebook) are typically filled with their likes and beliefs. This creates an environment where others with similar beliefs can distribute false information to one another, making it difficult for the expert commentary of healthcare professionals or public health services to be heard [3].

When confronted with something utterly uncharted, especially due to misinformation spread on social media, people are sometimes wary of governments [4]. During the COVID-19 pandemic, many fake pages and even well-known public figures contributed negatively to the crisis by spreading fake news, putting the public's trust in their governments to the test [5]. Vaccine hesitancy was also enhanced due to public mistrust of public and governmental authorities [5].

"Infodemic" refers to the impact of widespread dissemination of disease-related information, including false or misleading information, as reported by WHO [3]. Massive infodemics have accompanied the COVID-19 pandemic. The WHO resources include guidance around the art of ‘story-telling’. Misinformation narratives that go viral can be countered by story-telling with positive messages and here, public trusted figures (perhaps including celebrities or other famous individuals) can provide a positive input [6].

Untruths and misconceptions about the MPX, which are not well known, have already surfaced on social media and other platforms. These false claims include those repeated during the COVID-19 pandemic, for example, that MPX was created in a laboratory or that there is a link between COVID-19 vaccines and MPX prevalence [7]. This can also create stigma, particularly so here against gay communities who are broadly considered to be at the highest risk of monkeypox infection. High-level global groups such as UNAIDS have released statements urging “a rights-based, evidence-based approach that avoids stigma” [8]. The WHO is also considering renaming monkeypox, due to concerns around racism and media reporting that used photos of MPX lesions on Afro-Caribbean skin despite the outbreaks being mainly in countries with predominantly Caucasian populations [9].

Stigma can be addressed using mitigation frameworks [10] specifically modified for monkeypox that allow consideration of factors such as individual and family dynamics. This can then be used by civil society organizations to listen and co-create pertinent, useful, and accurate information for the general public, priority groups and communities It is vital that potential cases or those potentially exposed to MPX come forward to their local health services, and these individuals must be confident they will receive good discrete care and be given good public health advice.

To conclude, we recommend cooperation between policymakers, healthcare providers, mainstream media, and social media platforms by providing accurate official news about MPX, debunking circulating myths and misinformation. Mitigation frameworks can support consideration of multiple factors to proactively reduce potential sources of stigma. Public figures (for example, senior politicians or national leaders, social media activists, and famous celebrities) and the medical community can play a vital role by providing reassurance and communicating public health guidelines. There are numerous research gaps where the evidence base is weak or non-existent and expedited studies can be aiming to investigate most appropriate public health messaging and best practice in locally tailored health promotion. Policymakers can also review modes of communication between the healthcare worker and patient to build trust and confidence, thus promoting active and early seeking of healthcare.

Availability of data and materials

None.

Change history

  • 17 November 2022

    The family name of Dr. Mounir Ould Setti has been updated from “Setti" to “Ould Setti”.

Abbreviations

MPX:

Monkeypox

MPXV:

Monkeypox virus

WHO:

World Health Organization

References

  1. Kraemer MUG, Tegally H, Pigott DM, Dasgupta A, Sheldon J, Wilkinson E, et al. Tracking the 2022 monkeypox outbreak with epidemiological data in real-time. Lancet Infect Dis. 2022;22:941–2. https://doi.org/10.1016/S1473-3099(22)00359-0.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Enhance surveillance, public health measures for monkeypox: WHO n.d. https://www.who.int/southeastasia/news/detail/24-07-2022-enhance-surveillance--public-health-measures-for-monkeypox--who. Accessed 22 Aug 2022.

  3. Infodemic n.d. https://www.who.int/health-topics/infodemic#tab=tab_1. Accessed 11 Jul 2022.

  4. Vinck P, Pham PN, Bindu KK, Bedford J, Nilles EJ. Institutional trust and misinformation in the response to the 2018–19 Ebola outbreak in North Kivu, DR Congo: a population-based survey. Lancet Infect Dis. 2019;19:529–36. https://doi.org/10.1016/S1473-3099(19)30063-5.

    Article  PubMed  Google Scholar 

  5. Harapan H, Anwar S, Yufika A, Sharun K, Gachabayov M, Fahriani M, et al. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog Glob Health. 2022;116:236–43. https://doi.org/10.1080/20477724.2021.2011580.

    Article  CAS  PubMed  Google Scholar 

  6. Infodemic Management community event: The science of storytelling n.d. https://www.who.int/news-room/events/detail/2022/07/26/default-calendar/infodemic-management-community-event-the-science-of-science-storytelling%0A. Accessed 22 Aug 2022.

  7. Monkeypox wasn’t created in a lab - and other claims debunked n.d. https://www.bbc.com/news/health-61580089. Accessed 12 Jul 2022.

  8. UNAIDS warns that stigmatizing language on Monkeypox jeopardises public health n.d. https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2022/may/20220522_PR_Monkeypox%0A. Accessed 1 Aug 2022.

  9. Taylor L. Monkeypox: WHO to rename disease to prevent stigma. BMJ. 2022. https://doi.org/10.1136/bmj.o1489.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stangl AL, Earnshaw VA, Logie CH, van Brakel W, Simbayi LC, Barré I, et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17:31. https://doi.org/10.1186/s12916-019-1271-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

There was no funding for this study.

Author information

Authors and Affiliations

Authors

Contributions

RAF: the conception and design of the study. RAF, ST, and YA: acquisition of information, drafted the article, and final approval of the version to be submitted. RAF, MGH, MYE, BA, and MOS: revising it critically for important intellectual content, and final approval of the version to be submitted. RAF, MGH, MYE, BA, and MOS: interpretation of data, and revising it critically for important intellectual content. All the authors gave final approval of the version to be submitted. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Ramadan Abdelmoez Farahat or Mohammad Yasir Essar.

Ethics declarations

Ethics approval and consent to participate

None.

Consent for publication

All authors agreed for the publication of this manuscript.

Competing interest

The authors have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farahat, R.A., Head, M.G., Tharwat, S. et al. Infodemic and the fear of monkeypox: call for action. Trop Med Health 50, 63 (2022). https://doi.org/10.1186/s41182-022-00459-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41182-022-00459-8

Keywords